Skip to Content

PL PCR 37.5 (Paroxetine Extended-Release 37.5 mg)

Pill imprint PL PCR 37.5 has been identified as Paroxetine hydrochloride extended-release 37.5 mg.

Paroxetine is used in the treatment of anxiety and stress; anxiety; depression; obsessive compulsive disorder; postmenopausal symptoms (and more), and belongs to the drug class selective serotonin reuptake inhibitors. Excluding Brisdelle: There is positive evidence of human fetal risk during pregnancy. Brisdelle: Not for use in pregnancy. Paroxetine 37.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Paroxetine hydrochloride extended-release 37.5 mg PL PCR 37.5
Discount Card Promo
Paroxetine hydrochloride extended-release
PL PCR 37.5
37.5 mg
8.00 mm
Prescription only
Drug Class:
Selective serotonin reuptake inhibitors
Pregnancy Category:
D - Positive evidence of risk - excluding Brisdelle
X - Not for use in pregnancy - Brisdelle
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
16590-0896 Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.